Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22


Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.

Bhat KPL, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD, Conroy S, Long L, Lelic N, Wang S, Gumin J, Raj D, Kodama Y, Raghunathan A, Olar A, Joshi K, Pelloski CE, Heimberger A, Kim SH, Cahill DP, Rao G, Den Dunnen WFA, Boddeke HWGM, Phillips HS, Nakano I, Lang FF, Colman H, Sulman EP, Aldape K.

Cancer Cell. 2013 Sep 9;24(3):331-46. doi: 10.1016/j.ccr.2013.08.001. Epub 2013 Aug 29.


Using NanoDot dosimetry to study the RS 2000 X-ray biological irradiator.

Lu L, Bondra K, Gupta N, Sommerfeld J, Chronowski C, Leasure J, Singh M, Pelloski CE.

Int J Radiat Biol. 2013 Dec;89(12):1094-9. doi: 10.3109/09553002.2013.817703. Epub 2013 Jul 29.


Regulation of FANCD2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double-strand breaks.

Shen C, Oswald D, Phelps D, Cam H, Pelloski CE, Pang Q, Houghton PJ.

Cancer Res. 2013 Jun 1;73(11):3393-401. doi: 10.1158/0008-5472.CAN-12-4282. Epub 2013 Apr 30.


The application of radiation therapy to the Pediatric Preclinical Testing Program (PPTP): results of a pilot study in rhabdomyosarcoma.

Kaplon R, Hadziahmetovic M, Sommerfeld J, Bondra K, Lu L, Leasure J, Nguyen P, McHugh K, Li N, Chronowski C, Sebastian N, Singh M, Kurmasheva R, Houghton P, Pelloski CE.

Pediatr Blood Cancer. 2013 Mar;60(3):377-382. doi: 10.1002/pbc.24210. Epub 2012 Jun 12.


Diagnostic and prognostic molecular markers in common adult gliomas.

Rivera AL, Pelloski CE.

Expert Rev Mol Diagn. 2010 Jul;10(5):637-49. doi: 10.1586/erm.10.44.


Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.

Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, Verhaak RG, Hoadley KA, Hayes DN, Perou CM, Schmidt HK, Ding L, Wilson RK, Van Den Berg D, Shen H, Bengtsson H, Neuvial P, Cope LM, Buckley J, Herman JG, Baylin SB, Laird PW, Aldape K; Cancer Genome Atlas Research Network.

Cancer Cell. 2010 May 18;17(5):510-22. doi: 10.1016/j.ccr.2010.03.017. Epub 2010 Apr 15.


MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma.

Rivera AL, Pelloski CE, Gilbert MR, Colman H, De La Cruz C, Sulman EP, Bekele BN, Aldape KD.

Neuro Oncol. 2010 Feb;12(2):116-21. doi: 10.1093/neuonc/nop020. Epub 2009 Dec 14. Erratum in: Neuro Oncol. 2010 Jun;12(6):617.


A multigene predictor of outcome in glioblastoma.

Colman H, Zhang L, Sulman EP, McDonald JM, Shooshtari NL, Rivera A, Popoff S, Nutt CL, Louis DN, Cairncross JG, Gilbert MR, Phillips HS, Mehta MP, Chakravarti A, Pelloski CE, Bhat K, Feuerstein BG, Jenkins RB, Aldape K.

Neuro Oncol. 2010 Jan;12(1):49-57. doi: 10.1093/neuonc/nop007. Epub 2009 Oct 20.


Optimal treatment planning for skull base chordoma: photons, protons, or a combination of both?

Torres MA, Chang EL, Mahajan A, Lege DG, Riley BA, Zhang X, Lii M, Kornguth DG, Pelloski CE, Woo SY.

Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1033-9. doi: 10.1016/j.ijrobp.2008.09.029. Epub 2009 Apr 7.


Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications.

Williams BJ, Suki D, Fox BD, Pelloski CE, Maldaun MV, Sawaya RE, Lang FF, Rao G.

J Neurosurg. 2009 Sep;111(3):439-48. doi: 10.3171/2008.11.JNS08984.


Elevated phospho-S6 expression is associated with metastasis in adenocarcinoma of the lung.

McDonald JM, Pelloski CE, Ledoux A, Sun M, Raso G, Komaki R, Wistuba II, Bekele BN, Aldape K.

Clin Cancer Res. 2008 Dec 1;14(23):7832-7. doi: 10.1158/1078-0432.CCR-08-0565.


Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2.

Bhat KP, Pelloski CE, Zhang Y, Kim SH, deLaCruz C, Rehli M, Aldape KD.

FEBS Lett. 2008 Sep 22;582(21-22):3193-200. doi: 10.1016/j.febslet.2008.08.010. Epub 2008 Aug 15.


Prognostic and predictive markers in glioma and other neuroepithelial tumors.

Rivera AL, Pelloski CE, Sulman E, Aldape K.

Curr Probl Cancer. 2008 May-Jun;32(3):97-123. doi: 10.1016/j.currproblcancer.2008.02.003. Review. No abstract available.


Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.

Mahajan A, Woo SY, Kornguth DG, Hughes D, Huh W, Chang EL, Herzog CE, Pelloski CE, Anderson P.

Pediatr Blood Cancer. 2008 May;50(5):976-82. doi: 10.1002/pbc.21451.


Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.

Pelloski CE, Ballman KV, Furth AF, Zhang L, Lin E, Sulman EP, Bhat K, McDonald JM, Yung WK, Colman H, Woo SY, Heimberger AB, Suki D, Prados MD, Chang SM, Barker FG 2nd, Buckner JC, James CD, Aldape K.

J Clin Oncol. 2007 Jun 1;25(16):2288-94.


Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.

Pelloski CE, Lin E, Zhang L, Yung WK, Colman H, Liu JL, Woo SY, Heimberger AB, Suki D, Prados M, Chang S, Barker FG 3rd, Fuller GN, Aldape KD.

Clin Cancer Res. 2006 Jul 1;12(13):3935-41.


FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.

Liu M, Dai B, Kang SH, Ban K, Huang FJ, Lang FF, Aldape KD, Xie TX, Pelloski CE, Xie K, Sawaya R, Huang S.

Cancer Res. 2006 Apr 1;66(7):3593-602.


A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer.

Gifford KA, Horton JL Jr, Pelloski CE, Jhingran A, Court LE, Mourtada F, Eifel PJ.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):615-21.


YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.

Pelloski CE, Mahajan A, Maor M, Chang EL, Woo S, Gilbert M, Colman H, Yang H, Ledoux A, Blair H, Passe S, Jenkins RB, Aldape KD.

Clin Cancer Res. 2005 May 1;11(9):3326-34.


Supplemental Content

Loading ...
Support Center